Permeability of the intestinal epithelial and blood-brain barriers as therapeutic targets in inflammatory depression.
Inflammation has emerged as a compelling causal contributor to depression, serving both as a biological pathway underlying specific depressive symptoms (notably anhedonia, fatigue, and cognitive difficulties) and as a defining feature in a subtype of this disorder characterized by elevated levels of circulating cytokin...